Maged Shenouda insider trades

Open-market stock purchases and sales by Maged Shenouda, Chief Financial Officer at Relmada Therapeutics, Inc, from SEC Form 4 filings since Dec 14, 2015.

Track record: 92% of 13 scored buys are up 5% or more since purchase, averaging +74%.

Recent trades

DateStockTradeValue
Dec 15, 2025RLMD Relmada Therapeutics, IncBought$48.1K
Dec 12, 2025RLMD Relmada Therapeutics, IncBought (not open market)—
Nov 5, 2025RLMD Relmada Therapeutics, IncBought$1.1M

Companies traded

  • RLMD Relmada Therapeutics, Inc: 16 buys, 18 sales, last Dec 15, 2025
  • AZRX AzurRx BioPharma, Inc: 1 buy, last Dec 28, 2018
  • PRGB Protea Biosciences Group, Inc: other filings, last Dec 18, 2015

Get free alerts when Maged Shenouda files a new trade →